← Leaderboards
Irina Petrache
Johns Hopkins University
$14,015,590
Attributed
$22,224,479
Total exposure
12
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2006–25$2.5M$1.9M$1.3M$625K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$22,224,479 · 11
VA$0 · 1
By mechanism
R01$12,939,178 · 4
T32$5,653,794 · 1
R44$1,673,916 · 1
R56$683,614 · 1
K08$657,045 · 1
R21$417,725 · 1
Top collaborators
- Matthias Clauss6 shared
- David Albert Schwartz6 shared
- Keith Leonard March5 shared
- Ellen L Burnham4 shared
- Hong W Chu4 shared
- Lisa A Maier4 shared
- Evgeny V Berdyshev3 shared
- Kristina Anne Crothers2 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Enid R Neptune$11,248,461
- Steven R Kleeberger$929,417
- Elizabeth Wagner$9,262,640
- Robert H Brown$6,811,046
- John Matthew Craig$105,724
Others in their field
Top investigators on “Lung”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$372,040,227
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$201,818,043
- Walter John Curran · Thomas Jefferson University$112,093,071
Research focus
LungPulmonary EmphysemaApoptosisCellsInjuryEndothelial CellsChronic Obstructive Airway DiseaseAlveolarSignal TransductionEpithelial CellsCigarette SmokingChronicCigarette Smoke-InducedLinkSphingolipidsMediatingApoptoticPathogenesisCigarette SmokeResponseMolecularCell DeathCeramidesRegulation
Grant awards (59)
Multi-Disciplinary Research Training in Respiratory Disease$1,163,358
T32 · FY2025 · HL
Ceramide-Induced Destruction in Emphysema$676,133
R01 · FY2024 · HL · contact PI
Multi-Disciplinary Research Training in Respiratory Disease$670,419
T32 · FY2024 · HL
Multi-Disciplinary Research Training in Respiratory Disease$1,084,763
T32 · FY2023 · HL
Ceramide-Induced Destruction in Emphysema$681,732
R01 · FY2023 · HL · contact PI
Multi-Disciplinary Research Training in Respiratory Disease$723,629
T32 · FY2022 · HL
Ceramide-Induced Destruction in Emphysema$664,512
R01 · FY2022 · HL · contact PI
Multi-Disciplinary Research Training in Respiratory Disease$1,006,629
T32 · FY2021 · HL
Ceramide-Induced Destruction in Emphysema$639,212
R01 · FY2021 · HL · contact PI
Immunosuppressive injurious effects of e-cigarettes on human lung parenchyma$465,888
R01 · FY2021 · HL
Multi-Disciplinary Research Training in Respiratory Disease$1,004,996
T32 · FY2020 · HL
Immunosuppressive injurious effects of e-cigarettes on human lung parenchyma$474,847
R01 · FY2020 · HL
Ceramide-Induced Destruction In Emphysema$439,050
R01 · FY2020 · HL · contact PI
Immunosuppressive injurious effects of e-cigarettes on human lung parenchyma$483,551
R01 · FY2019 · HL
Ceramide-Induced Destruction In Emphysema$439,050
R01 · FY2019 · HL · contact PI
Development of a Fully Humanized Antibody for Treating Lung Emphysema$958,776
R44 · FY2018 · HL
Immunosuppressive injurious effects of e-cigarettes on human lung parenchyma$487,000
R01 · FY2018 · HL
Ceramide-Induced Destruction In Emphysema$439,050
R01 · FY2018 · HL · contact PI
Aspen Lung Conference on COPD: Translating Resilience and Pathogenesis to Personalized Therapy for COPD$30,000
R13 · FY2018 · HL
Development of a Fully Humanized Antibody for Treating Lung Emphysema$715,140
R44 · FY2017 · HL
Ceramide-Induced Destruction In Emphysema$445,450
R01 · FY2017 · HL · contact PI
Ceramide-induced Lung Destruction in Emphysema$320,023
R01 · FY2015 · HL · contact PI
Direct and Bone Marrow Mediated Effects of Adipose Stem Cells in Emphysema$267,138
R01 · FY2015 · HL · contact PI
Direct and Bone-Marrow Mediated Effects of Adipose Stem Cells in Emphysema$117,012
R01 · FY2015 · HL · contact PI
Ceramide-induced lung destruction in emphysema$41,144
R01 · FY2015 · HL · contact PI
Optimizing vascular protective effects of antitrypsin in COPD$0
I01 · FY2015 · VA · contact PI
Endothelial mechanisms of impaired lung gas exchange by HIV$572,938
R56 · FY2014 · HL · contact PI
Ceramide-induced lung destruction in emphysema$394,894
R01 · FY2014 · HL · contact PI
Direct and Bone-Marrow Mediated Effects of Adipose Stem Cells in Emphysema$382,200
R01 · FY2014 · HL · contact PI
Endothelial mechanisms of impaired lung gas exchange by HIV$110,676
R56 · FY2014 · HL · contact PI
Optimizing vascular protective effects of antitrypsin in COPD$0
I01 · FY2014 · VA · contact PI
Ceramide-induced lung destruction in emphysema$432,917
R01 · FY2013 · HL · contact PI
Direct and Bone-Marrow Mediated Effects of Adipose Stem Cells in Emphysema$371,280
R01 · FY2013 · HL · contact PI
Optimizing vascular protective effects of antitrypsin in COPD$0
I01 · FY2013 · VA · contact PI
Direct and Bone-Marrow Mediated Effects of Adipose Stem Cells in Emphysema$380,140
R01 · FY2012 · HL · contact PI
Ceramide-induced lung destruction in emphysema$367,891
R01 · FY2012 · HL · contact PI
Ceramide-induced lung destruction in emphysema$51,611
R01 · FY2012 · HL · contact PI
Optimizing vascular protective effects of antitrypsin in COPD$0
I01 · FY2012 · VA · contact PI
Ceramide-induced lung destruction in emphysema$381,561
R01 · FY2011 · HL · contact PI
EMAP II, a molecular link of inflammation and apoptosis in pulmonary emphysema.$375,446
R01 · FY2011 · HL
Molecular mechanism of alveolar injury caused by cigarette smoke$186,725
R21 · FY2011 · DA · contact PI
EMAP II, a molecular link of inflammation and apoptosis in pulmonary emphysema.$375,724
R01 · FY2010 · HL
Ceramide-induced lung destruction in emphysema$269,128
R01 · FY2010 · HL · contact PI
Molecular mechanism of alveolar injury caused by cigarette smoke$231,000
R21 · FY2010 · DA · contact PI
EMAP II, a molecular link of inflammation and apoptosis in pulmonary emphysema.$380,751
R01 · FY2009 · HL
Ceramide-induced lung destruction in emphysema$269,307
R01 · FY2009 · HL · contact PI
Ceramide-induced lung destruction in emphysema$215,093
R01 · FY2009 · HL · contact PI
Signaling Sphingolipids in COPD$51,603
R03 · FY2009 · HL
Signaling Sphingolipids in COPD$32,750
R03 · FY2009 · HL
EMAP II, a molecular link of inflammation and apoptosis in pulmonary emphysema.$368,800
R01 · FY2008 · HL
Ceramide-induced lung destruction in emphysema$269,481
R01 · FY2008 · HL · contact PI
Signaling Sphingolipids in COPD$84,854
R03 · FY2008 · HL
Ceramide-induced lung destruction in emphysema$270,496
R01 · FY2007 · HL · contact PI
Ceramide-induced lung destruction in emphysema$301,666
R01 · FY2006 · HL · contact PI
CYTOSKELETAL REGULATION OF ENDOTHELIAL CELL APOPTOSIS$131,490
K08 · FY2004 · HL
CYTOSKELETAL REGULATION OF ENDOTHELIAL CELL APOPTOSIS$131,490
K08 · FY2003 · HL
CYTOSKELETAL REGULATION OF ENDOTHELIAL CELL APOPTOSIS$131,490
K08 · FY2002 · HL
CYTOSKELETAL REGULATION OF ENDOTHELIAL CELL APOPTOSIS$131,490
K08 · FY2001 · HL
CYTOSKELETAL REGULATION OF ENDOTHELIAL CELL APOPTOSIS$131,085
K08 · FY2000 · HL